These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7473173

  • 1. Plasma digoxin immunoreactivity and arterial potassium relaxation after quinapril therapy in hypertensive rats.
    Kähönen M, Doris PA, Mäkynen H, Pörsti I.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):832-7. PubMed ID: 7473173
    [Abstract] [Full Text] [Related]

  • 2. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
    Kalliovalkama J, Kähönen M, Tolvanen JP, Wu X, Voipio J, Pekki A, Doris PA, Ylitalo P, Pörsti I.
    Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M, Mäkynen H, Wu X, Arvola P, Pekki A, Pörsti I.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [Abstract] [Full Text] [Related]

  • 4. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
    Arvola P, Ruskoaho H, Wuorela H, Pekki A, Vapaatalo H, Pörsti I.
    Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
    [Abstract] [Full Text] [Related]

  • 5. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.
    Kähönen M, Mäkynen H, Wu X, Arvola P, Pörsti I.
    Br J Pharmacol; 1995 Jul; 115(5):859-67. PubMed ID: 8548188
    [Abstract] [Full Text] [Related]

  • 6. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
    Kähönen M, Mäkynen H, Arvola P, Wuorela H, Pörsti I.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1223-30. PubMed ID: 7891337
    [Abstract] [Full Text] [Related]

  • 7. Vascular relaxation probably mediates the antihypertensive effect of a high-potassium diet: a role for enhanced vascular Na,K-ATPase activity.
    Dolson GM, Wesson DE, Adrogué HJ.
    J Hypertens; 1995 Dec; 13(12 Pt 1):1433-9. PubMed ID: 8866905
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of arterial relaxation by long-term atenolol treatment in spontaneously hypertensive rats.
    Kähönen M, Mäkynen H, Arvola P, Pörsti I.
    Br J Pharmacol; 1994 Jul; 112(3):925-33. PubMed ID: 7921622
    [Abstract] [Full Text] [Related]

  • 9. Effects of calcium and potassium supplements on arterial tone in vitro in spontaneously hypertensive rats.
    Tolvanen JP, Mäkynen H, Wu X, Hutri-Kähönen N, Ruskoaho H, Karjala K, Pörsti I.
    Br J Pharmacol; 1998 May; 124(1):119-28. PubMed ID: 9630351
    [Abstract] [Full Text] [Related]

  • 10. Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.
    Mäkynen H, Kähönen M, Wu X, Hutri-Kähönen N, Tolvanen JP, Pörsti I.
    Pharmacol Toxicol; 1997 Oct; 81(4):180-9. PubMed ID: 9353849
    [Abstract] [Full Text] [Related]

  • 11. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
    Teräväinen TL, Mervaala EM, Pörsti I, Laakso J, Vapaatalo H, Karppanen H.
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibition prevents polyploidization of cardiomyocytes in spontaneously hypertensive rats with left ventricular hypertrophy.
    Panizo-Santos A, Sola JJ, Pardo-Mindán FJ, Hernández M, Cenarruzabeitia E, Díez J.
    J Pathol; 1995 Dec; 177(4):431-7. PubMed ID: 8568599
    [Abstract] [Full Text] [Related]

  • 13. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats.
    Panizo A, Pardo J, Hernández M, Galindo MF, Cenarruzabeitia E, Díez J.
    Am J Hypertens; 1995 Aug; 8(8):815-22. PubMed ID: 7576398
    [Abstract] [Full Text] [Related]

  • 14. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [Abstract] [Full Text] [Related]

  • 15. Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity.
    Mäkynen H, Kähönen M, Arvola P, Wuorela H, Vapaatalo H, Pörsti I.
    Br J Pharmacol; 1995 Aug; 115(8):1455-62. PubMed ID: 8564205
    [Abstract] [Full Text] [Related]

  • 16. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
    Korbut RA, Madej J, Adamek-Guzik T, Korbut R.
    J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
    [Abstract] [Full Text] [Related]

  • 17. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC, Overhiser RW, Taylor DG, Panek RL.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [Abstract] [Full Text] [Related]

  • 18. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms underlying biochanin A-induced relaxation of the aorta differ between normotensive and hypertensive rats.
    Wang HP, Gao Q, Mei RH, Zhao MH, Lu Y, Li XY, Bruce IC, Xia Q.
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):802-7. PubMed ID: 16922810
    [Abstract] [Full Text] [Related]

  • 20. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O, Flesch M, Schnabel P, Teisman AC, Pinto YM, van Gilst WH, Paul M, Böhm M.
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.